Skip to main content
An official website of the United States government
Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Establishing Optimal Number of Doses for HPV Vaccination in Children and Adolescents Living With HIV, OPTIMO Trial

Major Program
US-Latin American-Caribbean U54
Research Group
Breast and Gynecologic Cancer
Sponsor
Fred Hutchinson Cancer Center
Status
Active, not recruiting
NCT ID
NCT04265950
This phase IV trial compares 3 different dosing schedules to find the optimal number of doses for HPV vaccination in children and adolescents living with HIV. Comparing 3 different dosing schedules may help researchers determine whether a single dose of HPV vaccine could be effective in preventing HPV in children and adolescents living with HIV.
Intervention
Recombinant Human Papillomavirus Nonavalent Vaccine
Condition
HIV Infection
Investigators
Ann Duerr, MD, PhD

See list of participating sites